Cargando…
Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
This review describes targeting neutrophils as a potential therapeutic strategy for acute respiratory distress syndrome (ARDS) associated with coronavirus disease 2019 (COVID-19), a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutrophil counts are significantly e...
Autores principales: | Chiang, Chih-Chao, Korinek, Michal, Cheng, Wei-Jen, Hwang, Tsong-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583590/ https://www.ncbi.nlm.nih.gov/pubmed/33162887 http://dx.doi.org/10.3389/fphar.2020.572009 |
Ejemplares similares
-
Neutrophils in Psoriasis
por: Chiang, Chih-Chao, et al.
Publicado: (2019) -
Understanding the role of neutrophils in acute respiratory distress syndrome
por: Yang, Shun-Chin, et al.
Publicado: (2021) -
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
por: Nagarkatti, Prakash, et al.
Publicado: (2020) -
Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019
por: Bifulco, Maurizio, et al.
Publicado: (2021) -
Apremilast ameliorates acute respiratory distress syndrome by inhibiting neutrophil-induced oxidative stress
por: Tsai, Yung-Fong, et al.
Publicado: (2023)